Giorgio Walter Canonica

77.1k total citations · 7 hit papers
1.0k papers, 33.8k citations indexed

About

Giorgio Walter Canonica is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giorgio Walter Canonica has authored 1.0k papers receiving a total of 33.8k indexed citations (citations by other indexed papers that have themselves been cited), including 673 papers in Physiology, 602 papers in Immunology and Allergy and 315 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giorgio Walter Canonica's work include Asthma and respiratory diseases (666 papers), Allergic Rhinitis and Sensitization (576 papers) and Respiratory and Cough-Related Research (233 papers). Giorgio Walter Canonica is often cited by papers focused on Asthma and respiratory diseases (666 papers), Allergic Rhinitis and Sensitization (576 papers) and Respiratory and Cough-Related Research (233 papers). Giorgio Walter Canonica collaborates with scholars based in Italy, United States and France. Giorgio Walter Canonica's co-authors include Giovanni Passalacqua, Giorgio Ciprandi, Jean Bousquet, Ilaria Baiardini, Torsten Zuberbier, Enrico Compalati, Carlos E. Baena‐Cagnani, Fulvio Braido, Marcello Bagnasco and Philippe‐Jean Bousquet and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Giorgio Walter Canonica

952 papers receiving 32.3k citations

Hit Papers

Allergic Rhinitis and its... 2004 2026 2011 2018 2010 2004 2010 2020 2009 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
    2010 1.3k citations Jan Brożek, Philippe‐Jean Bousquet et al. Journal of Allergy and Clinical Immunology profile →
  2. Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
    2004 839 citations Jean Bousquet, Giorgio Walter Canonica et al. Allergy profile →
  3. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1
    2010 590 citations Marcus Maurer, Philippe‐Jean Bousquet et al. Allergy profile →
  4. Allergic rhinitis
    2020 505 citations Jean Bousquet, Claus Bachert et al. profile →
  5. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria
    2009 496 citations Torsten Zuberbier, Giorgio Walter Canonica et al. Allergy profile →
  6. Biologics and airway remodeling in severe asthma
    2022 152 citations Gilda Varricchi, Emanuele Nappi et al. Allergy profile →
  7. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
    2023 82 citations Cezmi A. Akdiş, Claus Bachert et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giorgio Walter Canonica Italy 86 22.2k 20.2k 8.7k 8.2k 4.2k 1.0k 33.8k
Qutayba Hamid Canada 99 22.8k 1.0× 10.0k 0.5× 10.2k 1.2× 4.7k 0.6× 2.0k 0.5× 518 37.8k
Thomas B. Casale United States 61 10.3k 0.5× 8.1k 0.4× 4.2k 0.5× 2.8k 0.3× 2.2k 0.5× 447 15.8k
Pascal Demoly France 73 9.3k 0.4× 12.4k 0.6× 2.9k 0.3× 6.8k 0.8× 2.7k 0.6× 639 21.0k
Johannes Ring Germany 84 8.0k 0.4× 17.2k 0.9× 1.7k 0.2× 15.1k 1.8× 3.8k 0.9× 719 31.4k
Claus Bachert Belgium 93 18.9k 0.9× 18.9k 0.9× 5.7k 0.6× 2.6k 0.3× 1.8k 0.4× 702 33.3k
William W. Busse United States 102 26.3k 1.2× 8.4k 0.4× 16.8k 1.9× 1.6k 0.2× 1.8k 0.4× 559 34.6k
Torsten Zuberbier Germany 66 5.2k 0.2× 7.6k 0.4× 1.0k 0.1× 4.9k 0.6× 7.2k 1.7× 461 16.8k
Per Venge Sweden 85 11.2k 0.5× 4.9k 0.2× 7.2k 0.8× 1.2k 0.1× 3.5k 0.8× 568 31.8k
F. Estelle R. Simons Canada 67 6.1k 0.3× 9.2k 0.5× 2.5k 0.3× 2.6k 0.3× 1.6k 0.4× 224 14.4k
Paul M. O’Byrne Canada 96 30.4k 1.4× 7.6k 0.4× 22.7k 2.6× 1.4k 0.2× 1.0k 0.2× 556 38.1k

Countries citing papers authored by Giorgio Walter Canonica

Since Specialization
Citations

This map shows the geographic impact of Giorgio Walter Canonica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Walter Canonica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Walter Canonica more than expected).

Fields of papers citing papers by Giorgio Walter Canonica

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giorgio Walter Canonica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Walter Canonica. The network helps show where Giorgio Walter Canonica may publish in the future.

Co-authorship network of co-authors of Giorgio Walter Canonica

This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Walter Canonica. A scholar is included among the top collaborators of Giorgio Walter Canonica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Walter Canonica. Giorgio Walter Canonica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Juan, et al.. (2025). Systemic barrier dysfunction in type 2 inflammation diseases: perspective in the skin, airways, and gastrointestinal tract. Immunologic Research. 73(1). 60–60. 4 indexed citations
2.
3.
Sánchez, Jorge, Helena Pité, René Maximiliano Gómez, et al.. (2024). Chronic spontaneous urticaria remission definition and therapy stepping down: World Allergy Organization position paper. Journal of Allergy and Clinical Immunology. 155(3). 1050–1056.e2. 6 indexed citations
4.
Batard, Thierry, Giorgio Walter Canonica, Oliver Pfaar, et al.. (2023). Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling. Molecular Immunology. 155. 124–134. 6 indexed citations
5.
Latorre, Manuela, Riccardo Pistelli, Giovanna Elisiana Carpagnano, et al.. (2023). Symptom versus exacerbation control: an evolution in GINA guidelines?. Therapeutic Advances in Respiratory Disease. 17. 2683738589–2683738589. 1 indexed citations
6.
Canonica, Giorgio Walter, et al.. (2023). Real-world data: A relevant component in the framework of scientific evidence. Asia Pacific Allergy. 13(1). 40–43. 1 indexed citations
7.
Bleecker, Eugene R., Mona Al‐Ahmad, Leif Bjermer, et al.. (2022). Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group. World Allergy Organization Journal. 15(12). 100726–100726. 36 indexed citations
8.
Canonica, Giorgio Walter, Pierluigi Paggiaro, Francesco Blasi, et al.. (2021). Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies. Therapeutic Advances in Respiratory Disease. 15. 2663621862–2663621862. 10 indexed citations
9.
Feleszko, Wojciech, et al.. (2020). Immunoactive preparations and regulatory responses in the respiratory tract: potential for clinical application in chronic inflammatory airway diseases. Expert Review of Respiratory Medicine. 14(6). 603–619. 7 indexed citations
10.
Hellings, Peter W., Wytske J. Fokkens, Claus Bachert, et al.. (2017). Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement. Allergy. 72(9). 1297–1305. 89 indexed citations
11.
Varricchi, Gilda, Diego Bagnasco, Francesco Borriello, Enrico Heffler, & Giorgio Walter Canonica. (2016). Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders. Current Opinion in Allergy and Clinical Immunology. 16(2). 3 indexed citations
12.
13.
Canonica, Giorgio Walter, Gianenrico Senna, Patrick Mitchell, et al.. (2016). Therapeutic interventions in severe asthma. World Allergy Organization Journal. 9(1). 40–40. 34 indexed citations
14.
Braido, Fulvio, et al.. (2011). Disability in COPD and its relationship to clinical and patient-reported outcomes. Current Medical Research and Opinion. 27(5). 981–986. 31 indexed citations
15.
Fiocchi, Alessandro, Holger J. Schünemann, Jan Brożek, et al.. (2010). Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA): A summary report. Journal of Allergy and Clinical Immunology. 126(6). 1119–1128.e12. 200 indexed citations
16.
Baiardini, Ilaria, Philippe‐Jean Bousquet, Zenon Brzoza, et al.. (2009). Recommendations for assessing Patient‐Reported Outcomes and Health‐Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paper. Allergy. 65(3). 290–295. 78 indexed citations
17.
Albano, Monica, A Riccio, Laura Fregonese, et al.. (1999). Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial☆☆☆★. Journal of Allergy and Clinical Immunology. 104(5). 964–968. 129 indexed citations
18.
Canonica, Giorgio Walter, et al.. (1998). The impact of allergic rhinitis on quality of life and other airway diseases. Ghent University Academic Bibliography (Ghent University). 16 indexed citations
19.
Canonica, Giorgio Walter, William W. Busse, Leonardo M. Fabbri, et al.. (1997). Inflammation: Rhinitis and asthma. European Respiratory Review. 7(47). 286–287. 1 indexed citations
20.
Scudeletti, M., Giorgio Ciprandi, Caterina Pronzato, et al.. (1989). Comparison of the immunomodulation of prednisone, dexamethasone and deflazacort on T-cell activation pathways and gamma interferon production.. 5(2). 85–90. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qutayba Hamid Breakdown of academic impact, for papers by Thomas B. Casale Breakdown of academic impact, for papers by Pascal Demoly Breakdown of academic impact, for papers by Johannes Ring Breakdown of academic impact, for papers by Claus Bachert Breakdown of academic impact, for papers by William W. Busse Breakdown of academic impact, for papers by Torsten Zuberbier Breakdown of academic impact, for papers by Per Venge Breakdown of academic impact, for papers by F. Estelle R. Simons Breakdown of academic impact, for papers by Paul M. O’Byrne
Rankless by CCL
2026